High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trialCesare Gregoretti, Paolo Groff, Raffaele Scala et al.|Critical Care|2020Cited by 122
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trialClaudia Crimi, Andrea Cortegiani, Alberto Noto et al.|Thorax|2022Cited by 82